Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC)

NCT00351195 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

39

Enrollment

OTHER

Sponsor class

Stopped Did not meet the criteria for continuation to second stage

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Etoposide
DRUG: Oxaliplatin
DRUG: Capecitabine

Sponsor

Rigshospitalet, Denmark

Collaborators

[object Object]